Cannabis and Implications for Clinical Dental Practice

Presented by: Dr. José Lança

RCDSO Expiry Date: April 30, 2022

To qualify as a Core Category 1 course, the course certificate must be issued no later than this date.

RCDSO CE Points: 3, Category 1

Points can also be used as Category 2. For further information see our CE Points Page.

Click to close
  • Dr. José Lança MD, PhD

    Undergraduate Program Director in the Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto

    Dr. José Lança, MD, PhD is an Assistant Professor of Pharmacology in the Faculty of Dentistry and Faculty of Medicine, University of Toronto (UofT). He is also affiliated with the School of Graduate Studies and Centre for the Study of Pain at the UofT.

    Dr. Lança has been the Undergraduate Program Director in the Department of Pharmacology and Toxicology, Faculty of Medicine, at the UofT and has contributed extensively to curriculum development and teaching of pharmacology. He teaches and is the director of several undergraduate as well as graduate courses in Pharmacology and Therapeutics at the UofT.

    He has developed and taught courses and seminars in Continuing Medical and Dental Education. Dr. Lança is the author of several chapters in medical pharmacology textbooks. He has edited a pharmacology textbook and has published extensively in various areas including herbal medications, neuropharmacology, and pharmacology of alcoholism and drug abuse.

Current Status
Not Enrolled
Get Started

Cannabis is a commonly used drug with significant adverse effects and potential for abuse and dependence. Its therapeutic use for specific medical conditions – including neuropathic pain, spasticity in multiple sclerosis, analgesia in cancer patients and prevention of chemotherapy-induced nausea and vomiting – has been approved by Health Canada. Considering the recent legislative changes for the non-medical use of cannabis, it is expected that its use, adverse effects and risks will become more frequent. Therefore, it is important for healthcare professionals to increase awareness of the organization of the endocannabinoid system, cannabinoid exposure and implications for systemic and oral health.

In this presentation Dr. Lança will discuss: (1) the organization of the endocannabinoid system; (2) the mechanisms of action of cannabinoids in medical cannabinoids and in cannabis; (3) the adverse effects of cannabis smoking and ingesting on oral health (e.g., xerostomia, periodontal disease, caries, stomatitis and gingival hyperplasia); (4) the legal framework of non-medical cannabis use; (5) the clinically relevant interactions between cannabis and other compounds, including alcohol, opioids and sympathomimetics; (6) recommendations for prevention and management of non-medical use of cannabis.